CMG Pharmaceutical Co., Ltd. (KOSDAQ: 058820)
South Korea
· Delayed Price · Currency is KRW
1,914.00
+16.00 (0.84%)
Nov 15, 2024, 9:00 AM KST
CMG Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2019 | FY 2018 | FY 2017 |
Nov '24 Nov 14, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
Market Capitalization | 267,090 | 334,730 | 298,618 | 590,292 | 461,137 | 679,456 | |
Market Cap Growth | -6.44% | 12.09% | -49.41% | 28.01% | -32.13% | 96.55% | |
Enterprise Value | 260,900 | 285,069 | 182,746 | 466,997 | 406,460 | 622,516 | |
Last Close Price | 1923.00 | 2410.00 | 2150.00 | 4250.00 | 3945.03 | 5812.75 | |
PE Ratio | 116.11 | 52.39 | - | 170.00 | 70.83 | 223.57 | |
PS Ratio | 2.84 | 3.56 | 3.63 | 10.07 | 9.25 | 16.36 | |
PB Ratio | 1.38 | 1.76 | 1.61 | 3.28 | 4.43 | 6.94 | |
P/TBV Ratio | 1.59 | 1.82 | 1.64 | 3.30 | 4.48 | 7.01 | |
P/FCF Ratio | - | - | - | - | - | 572.17 | |
P/OCF Ratio | 38.46 | 84.99 | 60.48 | 209.07 | 520.01 | 348.78 | |
EV/Sales Ratio | 2.76 | 3.04 | 2.22 | 7.97 | 8.15 | 14.99 | |
EV/EBITDA Ratio | 30.99 | 50.96 | 34.70 | 99.16 | 92.05 | 182.08 | |
EV/EBIT Ratio | 49.99 | 93.87 | 61.30 | 179.35 | 158.17 | 397.98 | |
EV/FCF Ratio | -11.45 | - | - | - | - | 524.22 | |
Debt / Equity Ratio | 0.39 | 0.14 | 0.04 | 0.00 | - | - | |
Debt / EBITDA Ratio | 28.00 | 4.67 | 1.27 | 0.06 | - | - | |
Asset Turnover | 0.34 | 0.41 | - | 0.38 | 0.45 | 0.39 | |
Inventory Turnover | 2.71 | 2.41 | - | 3.38 | 3.30 | 3.29 | |
Quick Ratio | 1.33 | 3.79 | 4.58 | 15.12 | 8.50 | 6.67 | |
Current Ratio | 1.60 | 4.72 | 6.17 | 16.18 | 9.58 | 7.46 | |
Return on Equity (ROE) | 1.49% | 3.44% | - | 2.15% | 6.01% | 2.94% | |
Return on Assets (ROA) | -0.11% | 0.83% | - | 1.06% | 1.43% | 0.91% | |
Return on Capital (ROIC) | -0.12% | 0.93% | - | 1.14% | 1.59% | 1.01% | |
Earnings Yield | 0.86% | 1.93% | -0.13% | 0.52% | 1.32% | 0.42% | |
FCF Yield | -8.53% | -2.52% | -1.15% | -0.91% | -0.36% | 0.17% | |
Payout Ratio | 0.00% | 0.45% | - | - | - | - | |
Buyback Yield / Dilution | -20.78% | - | -14.27% | -11.63% | 0.14% | -19.21% | |
Total Shareholder Return | -20.78% | - | -14.27% | -11.63% | 0.14% | -19.21% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.